• English
  • 简体中文
  • 繁體中文
  • Tiếng Việt
  • ไทย
  • Indonesia
Subscribe
Real-time News
Federal Reserve Governor Milan: Interest rates are appropriate when they are well below current levels.February 10th - The National Labor Relations Board (NLRB) is dropping its years-long legal battle against Elon Musks SpaceX and hinted that it will recuse itself from future cases against the company. The NLRB announced it would withdraw its lawsuit two years after alleging the aerospace company fired eight engineers for participating in an open letter criticizing Musk. In a letter to the former employees lawyers, the NLRB cited a recent opinion from the National Mediation Board (NMB), which argued that SpaceX engineers fall under its jurisdiction, not the NLRBs.Federal Reserve Governor Milan will participate in the recording of the WBUR podcast in ten minutes.February 10th - According to foreign media reports, after a turbulent Monday as he struggled to retain his position, Starmer has consolidated his position as British Prime Minister. However, this is only a temporary respite. Insiders within the ruling Labour Party say that Starmer appears safe in the short term after receiving public support from all cabinet ministers, including potential rivals Wes Streeting, Ed Miliband, and another possible successor, former Deputy Prime Minister Angela Rayner. However, while Streeting stated, "Lets give Starmer a chance to clarify how he will lead us forward," he has not yet posted on X platform like his cabinet colleagues. This lukewarm support suggests that Streeting may be waiting for the right moment. Instead, he chose to release some of his text messages with Mandelson in an attempt to distance himself from criticism regarding his close relationship with Mandelson and his support for his ambassadorial appointment. One of Starmers allies stated that a silent majority within the Labour Party still does not want a change of leader.The Dow Jones Industrial Average rose 20.20 points, or 0.04%, to close at 50,135.87 on Monday, February 9; the S&P 500 rose 32.52 points, or 0.47%, to close at 6,964.82; and the Nasdaq Composite rose 207.46 points, or 0.90%, to close at 23,238.67.

Attorney General Martin O'Malley Announces $276 Million Opioid Settlement With J&J, McKesson, And Endo

Charlie Brooks

Apr 20, 2022 10:04

j2.png


McKesson will provide $141 million to the state's efforts to tackle the opioid problem, while Johnson & Johnson and Endo will contribute $70.3 million and $25 million, respectively, according to Alabama Attorney General Steve Marshall. Additionally, the three corporations will pay $40 million in legal expenses.


The state had charged McKesson with failing to prevent opioid diversion for criminal reasons and the drugmakers with false marketing techniques that minimized the addiction dangers associated with their medications. Both businesses have denied any wrongdoing.


J&J, the maker of Duragesic and Nucynta, claimed it no longer offers prescription opioids in the United States and that its previous marketing activities were "appropriate and acceptable."


McKesson and Endo did not reply to calls for comment immediately.


Alabama was one of four states that rejected to join a $26 billion national settlement of opioid lawsuits reached in February by McKesson, two other major U.S. distributors, and J&J. [L1N2V01ZA]


"These three settlement agreements reaffirm my decision to withdraw from the national opioid settlements, which failed to sufficiently recognize the specific suffering suffered by Alabama residents," Marshall said in a statement.


Alabama would get a larger payment from McKesson and a speedier payment from J&J, Marshall said, compared to what the state would have gotten under the national settlement.


Alabama would have earned $115 million over 18 years from McKesson and $70.3 million over nine years from J&J under the national settlement structure. According to Marshall, the revised deal requires J&J to make full payment within a year, while McKesson will do so within nine years.


The state was on the point of bringing McKesson to trial, with opening arguments slated on Monday until the two parties agreed to a postponement.


Alabama's agreement comes amid a flood of state government lawsuits and settlements over the United States' opioid problem, which has resulted in more than 500,000 overdose fatalities over the last two decades, according to the United States Centers for Disease Control and Prevention.


West Virginia announced a $99 million settlement with Johnson & Johnson on Monday and is currently prosecuting drugmakers Teva Pharmaceutical Industries (NYSE:TEVA) and AbbVie's Allergan (NYSE:AGN) subsidiary.


In March, Florida achieved opioid settlements totaling more than $878 million with CVS Health Corp (NYSE:CVS) and three pharmaceutical firms, and on April 11, the state opened a trial against drugstore chain Walgreens Boots Alliance (NASDAQ:WBA).